Clinical factors associated with brain volume reduction in systemic lupus erythematosus patients without major neuropsychiatric manifestations
文献类型：期刊论文
| 作者 | Liu, Shuang1; Cheng, Yuqi2; Zhao, Yueyin1; Yu, Hongjun3; Lai, Aiyun1; Lv, Zhaoping1; Xu, Xiufeng2; Luo, Chunrong3; Shan, Baoci4; Xu, Lin5 |
| 刊名 | Frontiers in psychiatry
 |
| 出版日期 | 2018-02-01 |
| 卷号 | 9页码:7 |
| ISSN号 | 1664-0640 |
| 关键词 | Systemic lupus erythematosus Quantitative magnetic resonance imaging Brain volume reduction Cognitive impairment Immunosuppressive agents |
| DOI | 10.3389/fpsyt.2018.00008 |
| 通讯作者 | Xu, jian(casxujian@163.com) |
| 英文摘要 | The aim of the study was to find structural brain changes in systemic lupus erythematosus patients without major neuropsychiatric manifestations [non-neuropsychiatric systemic lupus erythematosus (non-npsle)] using quantitative magnetic resonance imaging (mri) and possible associations with clinical characteristics. 89 non-npsle patients with normal conventional mri and 84 healthy controls (hcs) were recruited. the whole brain gray matter volume (gmv) and white matter volume (wmv) were calculated for each individual. we found obvious gmv and wmv reduction in the systemic lupus erythematosus (sle) group compared with hcs. female patients showed significant reduction of gmv and wmv compared with male patients. patients treated with immunosuppressive agents (isa) showed less wmv reduction than those without. cognitive impairment was the most common subclinical neuropsychiatric manifestation and had a prevalence of 46.1%. association between wmv reduction with cognitive impairment was found. thus, we concluded that structural brain atrophy could happen even before occurrence of obvious neuropsychiatric signs and symptoms and was associated with subclinical symptoms such as cognitive impairment. isa treatment might have a protective effect on the brain atrophy. early treatment might prevent the progressive damage to the brain. more studies are needed to fully understand the complicated underlying mechanisms of brain atrophy in sle. |
| WOS关键词 | CENTRAL-NERVOUS-SYSTEM ; DISEASE-ACTIVITY INDEX ; MAGNETIC-RESONANCE ; INTRAVENOUS CYCLOPHOSPHAMIDE ; ANTIPHOSPHOLIPID ANTIBODIES ; ANTICARDIOLIPIN ANTIBODIES ; HIPPOCAMPAL ATROPHY ; MRI ; DEPRESSION ; GRAY |
| WOS研究方向 | Psychiatry |
| WOS类目 | Psychiatry |
| 语种 | 英语 |
| 出版者 | FRONTIERS MEDIA SA |
| WOS记录号 | WOS:000423809500001 |
| URI标识 | http://www.irgrid.ac.cn/handle/1471x/2177934 |
| 专题 | 高能物理研究所 |
| 通讯作者 | Xu, Jian |
| 作者单位 | 1.Kunming Med Univ, Affiliated Hosp 1, Dept Rheumatol & Immunol, Kunming, Yunnan, Peoples R China 2.Kunming Med Univ, Affiliated Hosp 1, Dept Psychiat, Kunming, Yunnan, Peoples R China 3.First Hosp Kunming, Magnet Resonance Imaging Ctr, Kunming, Yunnan, Peoples R China 4.Chinese Acad Sci, Inst High Energy Phys, Key Lab Nucl Anal, Beijing, Peoples R China 5.Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China |
| 推荐引用方式 GB/T 7714 | Liu, Shuang,Cheng, Yuqi,Zhao, Yueyin,et al. Clinical factors associated with brain volume reduction in systemic lupus erythematosus patients without major neuropsychiatric manifestations[J]. Frontiers in psychiatry,2018,9:7. |
| APA | Liu, Shuang.,Cheng, Yuqi.,Zhao, Yueyin.,Yu, Hongjun.,Lai, Aiyun.,...&Xu, Jian.(2018).Clinical factors associated with brain volume reduction in systemic lupus erythematosus patients without major neuropsychiatric manifestations.Frontiers in psychiatry,9,7. |
| MLA | Liu, Shuang,et al."Clinical factors associated with brain volume reduction in systemic lupus erythematosus patients without major neuropsychiatric manifestations".Frontiers in psychiatry 9(2018):7. |
入库方式： iSwitch采集
来源：高能物理研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。